All Stories

  1. Advances in Alphavirus and Flavivirus Research II

    Article • Viruses, March 2026, MDPI AG

    Prof Arturo Reyes-Sandoval

  2. Recent Advances in Vaccine Development for Flaviviruses and Alphaviruses

    Article • Vaccines, July 2025, MDPI AG

    Prof Arturo Reyes-Sandoval

  3. Chikungunya Virus: Priority Pathogen or Passing Trend?

    Article • Vaccines, March 2023, MDPI AG

    Prof Arturo Reyes-Sandoval

  4. Recent Developments in Vaccines against Flaviviruses and Alphaviruses

    Article • Vaccines, February 2023, MDPI AG

    Prof Arturo Reyes-Sandoval

  5. Parameters to Predict the Outcome of Severe and Critical COVID-19 Patients when Admitted to the Hospital

    Article • Journal of Clinical Medicine, February 2023, MDPI AG

    Prof Arturo Reyes-Sandoval

  6. Vaccines Against SARS-CoV-2. Eradicating COVID-19

    Article • September 2022, Bentham Science Publishers

    Prof Arturo Reyes-Sandoval

  7. Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus

    Article • International Journal of Molecular Sciences, April 2022, MDPI AG

    Prof Arturo Reyes-Sandoval

  8. Cutting Edge: Subunit Booster Vaccination Confers Sterilizing Immunity against Liver-Stage Malaria in Mice Initially Primed with a Weight-Normalized Dose of Radiation-Attenuated Sporozoites

    Article • The Journal of Immunology, December 2021, Oxford University Press (OUP)

    Prof Arturo Reyes-Sandoval

  9. Dengue Virus Induces the Expression and Release of Endocan from Endothelial Cells by an NS1–TLR4-Dependent Mechanism

    Article • Microorganisms, June 2021, MDPI AG

    Prof Arturo Reyes-Sandoval

  10. A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development

    Article • npj Vaccines, April 2021, Springer Science + Business Media

    Prof Arturo Reyes-Sandoval

  11. Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination

    Article • EMBO Molecular Medicine, March 2021, Springer Science + Business Media

    Prof Arturo Reyes-Sandoval

  12. Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform

    Article • npj Vaccines, October 2020, Springer Science + Business Media

    Prof Arturo Reyes-Sandoval

  13. Importance of the Immunodominant CD8+T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection

    Article • Infection and Immunity, September 2020, ASM Journals

    Prof Arturo Reyes-Sandoval

  14. Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination

    Article • September 2020, Cold Spring Harbor Laboratory Press

    Prof Arturo Reyes-Sandoval

  15. Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells—Comparison of Their Performances in ELISA

    Article • Viruses, August 2020, MDPI AG

    Prof Arturo Reyes-Sandoval

  16. Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates

    Article • Vaccines, July 2020, MDPI AG

    Prof Arturo Reyes-Sandoval

  17. Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines

    Article • Vaccines, June 2020, MDPI AG

    Prof Arturo Reyes-Sandoval

  18. Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein

    Article • Vaccine, June 2020, Elsevier

    Prof Arturo Reyes-Sandoval

  19. Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection

    Article • PLoS Neglected Tropical Diseases, April 2020, PLOS

    Prof Arturo Reyes-Sandoval

  20. Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention

    Article • Vaccines, December 2019, MDPI AG

    Prof Arturo Reyes-Sandoval

  21. A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease

    Article • Pathogens, November 2019, MDPI AG

    Prof Arturo Reyes-Sandoval

  22. Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers

    Article • Pathogens, November 2019, MDPI AG

    Prof Arturo Reyes-Sandoval

  23. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection

    Article • Nature Immunology, September 2019, Springer Science + Business Media

    Prof Arturo Reyes-Sandoval

  24. Immunity conferred by drug-cured experimental Trypanosoma cruzi infections is long-lasting and cross-strain protective

    Article • August 2019, Cold Spring Harbor Laboratory Press

    Prof Arturo Reyes-Sandoval

  25. Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

    Article • Scientific Reports, May 2019, Springer Science + Business Media

    Prof Arturo Reyes-Sandoval

  26. 51 years in of Chikungunya clinical vaccine development: A historical perspective

    Article • Human Vaccines & Immunotherapeutics, February 2019, Taylor & Francis

    Prof Arturo Reyes-Sandoval

  27. A Zika vaccine based on chimpanzee adenovirus ChAdOx1 elicits lineage-transcending sterile immunity and prevents colonisation of brain and ovaries

    Article • January 2019, Cold Spring Harbor Laboratory Press

    Prof Arturo Reyes-Sandoval

  28. A probabilistic model of pre-erythrocytic malaria vaccine combination in mice

    Article • PLOS One, January 2019, PLOS

    Prof Arturo Reyes-Sandoval

  29. Rapid travel to a Zika vaccine: are we heading towards success or more questions?

    Article • Expert Opinion on Biological Therapy, October 2018, Taylor & Francis

    Prof Arturo Reyes-Sandoval

  30. Tailoring aPlasmodium vivaxVaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors

    Article • Infection and Immunity, July 2018, ASM Journals

    Prof Arturo Reyes-Sandoval

  31. Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

    Article • Scientific Reports, August 2017, Nature

    Prof Arturo Reyes-Sandoval

  32. Detecting circulating antibodies by controlled surface modification with specific target proteins: Application to malaria

    Article • Biosensors and Bioelectronics, May 2017, Elsevier

    Prof Arturo Reyes-Sandoval, Goreti Sales

  33. A highly protective P. vivax CSP vaccine

    Article • Scientific Reports, April 2017, Nature

    Prof Arturo Reyes-Sandoval

  34. Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine

    Article • Clinical and Vaccine Immunology, February 2017, ASM Journals

    Prof Arturo Reyes-Sandoval

  35. Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses

    Article • Vaccine, August 2016, Elsevier

    Prof Arturo Reyes-Sandoval

  36. Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles

    Article • PLOS One, February 2016, PLOS

    Prof Arturo Reyes-Sandoval

  37. Tailoring a Combination Preerythrocytic Malaria Vaccine

    Article • Infection and Immunity, December 2015, ASM Journals

    Prof Arturo Reyes-Sandoval

  38. Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand

    Article • Clinical and Vaccine Immunology, December 2015, ASM Journals

    Prof Arturo Reyes-Sandoval

  39. Transient IL-10 receptor blockade can enhance CD8+T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen

    Article • Human Vaccines & Immunotherapeutics, March 2015, Taylor & Francis

    Prof Arturo Reyes-Sandoval

  40. Efficacy of a Plasmodium vivax Malaria Vaccine Using ChAd63 and Modified Vaccinia Ankara Expressing Thrombospondin-Related Anonymous Protein as Assessed with Transgenic Plasmodium berghei Parasites

    Article • Infection and Immunity, December 2013, ASM Journals

    Prof Arturo Reyes-Sandoval

  41. Plasmodium vivax malaria vaccines: Why are we where we are?

    Article • Human Vaccines & Immunotherapeutics, December 2013, Taylor & Francis

    Prof Arturo Reyes-Sandoval

  42. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

    Article • Nature Communications, November 2013, Springer Science + Business Media

    Dr Simon J Draper, Prof Arturo Reyes-Sandoval

  43. Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques

    Article • Clinical and Vaccine Immunology, February 2013, ASM Journals

    Prof Arturo Reyes-Sandoval

  44. Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice

    Article • Virology Journal, January 2013, Springer Science + Business Media

    Prof Arturo Reyes-Sandoval

  45. Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection

    Article • PLOS One, December 2012, PLOS

    Prof Arturo Reyes-Sandoval

  46. A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP

    Article • Malaria Journal, October 2012, Springer Science + Business Media

    Prof Arturo Reyes-Sandoval

  47. Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity

    Article • Molecular Therapy, August 2012, Elsevier

    Prof Arturo Reyes-Sandoval

  48. Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses

    Article • PLOS One, March 2012, PLOS

    Prof Arturo Reyes-Sandoval

  49. Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine

    Article • Journal of Virology, February 2012, ASM Journals

    Professor Peter Liljeström, Prof Arturo Reyes-Sandoval

  50. Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

    Article • The Journal of Infectious Diseases, January 2012, Oxford University Press (OUP)

    Prof Arturo Reyes-Sandoval

  51. CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria

    Article • The Journal of Immunology, June 2011, The American Association of Immunologists

    Prof Arturo Reyes-Sandoval

  52. Viral vectors as vaccine platforms: deployment in sight

    Article • Current Opinion in Immunology, June 2011, Elsevier

    Prof Arturo Reyes-Sandoval

  53. Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

    Article • European Journal of Immunology, April 2011, Wiley

    Prof Arturo Reyes-Sandoval

  54. Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+T-Cell Responses

    Article • Infection and Immunity, April 2011, ASM Journals

    Prof Arturo Reyes-Sandoval

  55. Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime–boost immunisation in non-human primates

    Article • Vaccine, December 2010, Elsevier

    Prof Arturo Reyes-Sandoval

  56. Prime-boost vectored malaria vaccines: Progress and prospects

    Article • Human Vaccines, January 2010, Taylor & Francis

    Dr Simon J Draper, Prof Arturo Reyes-Sandoval

  57. Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T-Cell Responses

    Article • Infection and Immunity, October 2009, ASM Journals

    Prof Arturo Reyes-Sandoval

  58. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria

    Article • Proceedings of the National Academy of Sciences, September 2008, Proceedings of the National Academy of Sciences

    Prof Arturo Reyes-Sandoval

  59. Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

    Article • European Journal of Immunology, February 2008, Wiley

    Prof Arturo Reyes-Sandoval

  60. Single-Dose Protection against Plasmodium berghei by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A

    Article • Journal of Virology, February 2008, ASM Journals

    Dr Simon J Draper, Prof Arturo Reyes-Sandoval

  61. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines

    Article • Blood, May 2007, American Society of Hematology

    Prof Arturo Reyes-Sandoval

  62. Viral vector vaccines make memory T cells against malaria

    Article • Immunology, January 2007, Wiley

    Prof Arturo Reyes-Sandoval

  63. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1

    Article • Microbes and Infection, December 2005, Elsevier

    Prof Arturo Reyes-Sandoval

  64. Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

    Article • Journal of Virology, March 2005, ASM Journals

    Prof Arturo Reyes-Sandoval

  65. Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes

    Article • Journal of Virology, July 2004, ASM Journals

    Prof Arturo Reyes-Sandoval

  66. CpG Methylation of a Plasmid Vector Results in Extended Transgene Product Expression by Circumventing Induction of Immune Responses

    Article • Molecular Therapy, February 2004, Elsevier

    Prof Arturo Reyes-Sandoval

  67. Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

    Article • Journal of Virology, October 2003, ASM Journals

    Prof Arturo Reyes-Sandoval

  68. Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus

    Article • Cellular Immunology, August 2003, Elsevier

    Prof Arturo Reyes-Sandoval

  69. Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product

    Article • Journal of Virology, March 2002, ASM Journals

    Prof Arturo Reyes-Sandoval

  70. DNA Vaccines.

    Article • Current Molecular Medicine, May 2001, Bentham Science Publishers

    Prof Arturo Reyes-Sandoval